AU2001248365A1 - 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives - Google Patents
2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivativesInfo
- Publication number
- AU2001248365A1 AU2001248365A1 AU2001248365A AU4836501A AU2001248365A1 AU 2001248365 A1 AU2001248365 A1 AU 2001248365A1 AU 2001248365 A AU2001248365 A AU 2001248365A AU 4836501 A AU4836501 A AU 4836501A AU 2001248365 A1 AU2001248365 A1 AU 2001248365A1
- Authority
- AU
- Australia
- Prior art keywords
- pyrimidone derivatives
- heteroarylalkylamino
- arylalkylamino
- pyrimidone
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00400805 | 2000-03-23 | ||
| EP00400806A EP1136491A1 (en) | 2000-03-23 | 2000-03-23 | 2-[(Heteroaryl)alkylamino]pyrimidone derivatives |
| EP00400805A EP1136099A1 (en) | 2000-03-23 | 2000-03-23 | 2-(Indolylalkylamino)pyrimidone derivatives as GSK3beta inhibitors |
| EP00400804 | 2000-03-23 | ||
| JP2000-81938 | 2000-03-23 | ||
| EP00400806 | 2000-03-23 | ||
| JP2000081938A JP2001270884A (en) | 2000-03-23 | 2000-03-23 | Pyrimidone derivative |
| EP00400804A EP1136484A1 (en) | 2000-03-23 | 2000-03-23 | 2-(Arylalkylamino)pyrimidone derivatives |
| PCT/EP2001/003638 WO2001070727A1 (en) | 2000-03-23 | 2001-03-22 | 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001248365A1 true AU2001248365A1 (en) | 2001-10-03 |
Family
ID=27440051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001248365A Abandoned AU2001248365A1 (en) | 2000-03-23 | 2001-03-22 | 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR028281A1 (en) |
| AU (1) | AU2001248365A1 (en) |
| WO (1) | WO2001070727A1 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1283056B1 (en) | 2000-04-26 | 2004-12-15 | Eisai Co., Ltd. | Medicinal compositions promoting bowel movement |
| TWI335221B (en) * | 2001-09-27 | 2011-01-01 | Alcon Inc | Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| TWI301834B (en) | 2001-10-22 | 2008-10-11 | Eisai R&D Man Co Ltd | Pyrimidone compound and pharmaceutical composition including the same |
| TWI330183B (en) | 2001-10-22 | 2010-09-11 | Eisai R&D Man Co Ltd | |
| US20050203059A1 (en) * | 2002-03-01 | 2005-09-15 | Harrison Stephen D. | Methods and compositions for treatment of ischemia |
| BR0309623A (en) | 2002-04-30 | 2005-02-09 | Alcon Inc | Regulating Agents. inhibit or modulate connective tissue growth factor (ctgf) activity and / or expression as a sole means of decreasing intraocular pressure and treating glaucomatous retinopathies / optic neuropathies |
| EP1925306A3 (en) * | 2002-04-30 | 2008-09-17 | Alcon, Inc. | Agents which Regulate, Inhibit, or Modulate the Activity and/or Expression of Connective Tissue Growth Factor (CTGF) to Lower Intraocular Pressure |
| US6989382B2 (en) | 2002-10-21 | 2006-01-24 | Chiron Corporation | Carbocycle based inhibitors of glycogen synthase kinase 3 |
| WO2005076854A2 (en) * | 2004-02-04 | 2005-08-25 | Smithkline Beecham Corporation | Pyrimidinone compounds useful as kinase inhibitors |
| JP2008535779A (en) | 2005-01-07 | 2008-09-04 | エモリー・ユニバーシテイ | CXCR4 antagonist for the treatment of HIV infection |
| EP1928437A2 (en) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| CA2625153A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| JP2009543802A (en) * | 2006-07-11 | 2009-12-10 | エモリー・ユニバーシテイ | CXCR4 antagonists containing diazine and triazine structures for the treatment of medical diseases |
| US9180118B2 (en) | 2006-07-18 | 2015-11-10 | University Of Rochester | Thiadiazolidinone derivatives |
| ATE530540T1 (en) * | 2006-08-23 | 2011-11-15 | Pfizer Prod Inc | PYRIMIDONE COMPOUNDS AS GSK-3 INHIBITORS |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2009058216A1 (en) * | 2007-11-01 | 2009-05-07 | Acucela, Inc. | Amine derivative compounds for treating ophthalmic diseases and disorders |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW520362B (en) * | 1996-12-05 | 2003-02-11 | Amgen Inc | Substituted pyrimidine compounds and pharmaceutical composition comprising same |
-
2001
- 2001-03-22 AU AU2001248365A patent/AU2001248365A1/en not_active Abandoned
- 2001-03-22 WO PCT/EP2001/003638 patent/WO2001070727A1/en not_active Application Discontinuation
- 2001-03-23 AR ARP010101373A patent/AR028281A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR028281A1 (en) | 2003-04-30 |
| WO2001070727A1 (en) | 2001-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001248365A1 (en) | 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives | |
| AU2002226486A1 (en) | Novel c-glycoside derivatives and use thereof | |
| AU2001266583A1 (en) | Epothilone derivatives and methods for making and using the same | |
| AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
| AU2002226487A1 (en) | Novel c-glycoside derivatives and use thereof | |
| AU2001277754A1 (en) | Proline derivatives and use thereof as drugs | |
| AU2002225356A1 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | |
| AU2001230338A1 (en) | Isothiazole derivatives and their use as pesticides | |
| AU2001281850A1 (en) | Use of inulin and inulin derivatives | |
| AU2001269175A1 (en) | Diamino phenothiazine derivatives and composition comprising same | |
| AU6124999A (en) | Hydrazinooxoacetamide derivatives and insecticide | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AU2001228667A1 (en) | Isothiazole derivatives and their use as pesticides | |
| AU2001248820A1 (en) | Thiazole and oxazole derivatives | |
| AU2001262149A1 (en) | 2-(indanylamino)pyrimidone and 2-(tetrahydronaphthalenylamino)pyrimidone derivatives | |
| AU7271600A (en) | Quinazolinone and azaquinazolinone derivatives | |
| AU2002308891A1 (en) | Novel heterocyclic derivatives and medicinal use thereof | |
| AU2001230355A1 (en) | Benzoxazole derivatives and their use as pesticides | |
| AU2001230358A1 (en) | Isothiazole derivatives and their use as pesticides | |
| AU2002216650A1 (en) | Triazine derivatives as lpaat-b inhibitors and uses thereof | |
| AU2001229439A1 (en) | Bioconjugates and uses thereof | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AU2001261375A1 (en) | Human caspase-12 materials and methods | |
| AU2002219176A1 (en) | Dihydroindole and tetrahydroquinoline derivatives | |
| AU2002338989A1 (en) | Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives |